( October 9, 2024, 9:16 AM EDT) -- AMARILLO, Texas — Parties in a lawsuit challenging the U.S. Food and Drug Administration’s approval of abortion drug mifepristone offered the district court varying opinions on how to proceed in light of the U.S. Supreme Court’s finding that a group of anti-abortion advocates lacked standing in its challenge to the approval because they had no injury....